SecBot SecBot
Insider Cluster (4 insiders) ·Filed Mar 13, 2026

STOK

Stoke Therapeutics, Inc.
BEARISH
Impact 6/10
Horizondays Processed7mo ago
Insider cluster: 5 insiders, $0.5M total
Actionable Insight ▼ Bearish

Monitor for upcoming earnings or clinical trial updates; coordinated selling by multiple C-suite executives may signal lack of near-term confidence despite recent price strength. Consider hedging if positioned long.

DirectionBearish
Confidencehigh
Horizondays

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$33.19
T+0 close · Mar 12, 2026 · via day close
Latest settled
−12.62%
T+60 · $29.00
Vs SPY
−24.24%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 13 $33.19entry
  2. T+1 · 8mo ago +2.32%α +1.30% · $33.96
  3. T+5 · 8mo ago +0.96%α +3.08% · $33.51
  4. T+20 · 7mo ago +5.60%α +2.02% · $35.05
  5. T+60 · 5mo ago −12.62%α −24.24% · $29.00
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Seven open-market share sales by four insiders at Stoke Therapeutics over the past week, including the CFO, Chief Medical Officer, General Counsel, and Chief Patient Officer, totaled approximately $772,200 in proceeds. The transactions include both routine sales and derivative exercises, with the majority of economic activity representing open-market selling.

Key Financial Metrics

Direction
selling
Total Value
$772.2K
Insiders
4

Key Facts

  • CFO (Leggett Thomas) sold $67,980 worth of shares in open-market transaction
  • Chief Medical Officer (Ticho Barry) sold $234,647 in shares and exercised derivatives for 2,730 shares (non-cash value of $2,989)
  • General Counsel (Allan Jonathan) sold $424,439 in shares across two days
  • Total open-market sales by insiders: $772,207
  • All sales occurred between $29.99 and $33.64 per share
  • No open-market purchases reported in the cluster

Financial Impact

$772,207 in net insider selling over 7 days

insider sentimentshareholder dilution perceptionmarket confidence

Risk Factors

  • Perception of insider pessimism due to absence of offsetting buys
  • Potential for further selling if near-term catalysts disappoint

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (8 trades, 7d window)cluster-STOK-1774383582951

Track record

18 reports on STOK

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +17.49% at T+60 after the Aug 3, 2026 report. 3 of 4 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry price pending
  2. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $27.02 Now $26.63 −1.44% settles Feb 12
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry price pending
  4. Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $26.12 Now $26.63 +1.95% settles Feb 12
  5. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $26.07 Now $26.63 +2.15% settles Feb 3
  6. Oct 29, 202618d ago 8-K Neutral 5/10 Entry $26.29 Now $26.63 +1.29% settles Jan 28
  7. Oct 21, 202626d ago 144 Bearish 6/10 Entry $25.70 Now $26.63 −3.62% settles Jan 20
  8. Sep 30, 20266w ago SC 13G Neutral 4/10 Entry $26.01 Now $26.63 +2.38% settles Dec 28
  9. Sep 25, 20267w ago 8-K Neutral 2/10 Entry $25.50 Now $26.63 +4.43% settles Dec 22
  10. Aug 18, 202612w ago Insider Cluster Neutral 3/10 Entry $33.03 to $26.20 Now $26.63 −19.38% ▼ −20.68% −19.13% vs SPY
Showing 10 of 18

US Market Status

Market Closed · Opens Wed (11h 11m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 24, 2026